Norges Bank’s AstraZeneca AZN Stock Holding History

Norges Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-638,091	Closed	-$117M	–	148
2025 Q4	$117M	Buy	+638,091	New	+$112M	0.01%	695
2025 Q3	–	Sell	-30,189	Closed	-$4.22M	–	167
2025 Q2	$4.22M	Buy	30,189 +22,000	+269%	+$3.08M	﹤0.01%	1344
2025 Q1	$1.2M	Hold	8,189	–	–	﹤0.01%	1598
2024 Q4	$1.07M	Sell	8,189 -52,206	-86%	-$7.31M	﹤0.01%	1753
2024 Q3	$9.41M	Hold	60,395	–	–	﹤0.01%	1379
2024 Q2	$9.42M	Sell	60,395 -305,113	-83%	-$45.9M	﹤0.01%	1408
2024 Q1	$49.5M	Sell	365,508 -703,527	-66%	-$93.2M	0.01%	947
2023 Q4	$144M	Sell	1,069,035 -466,955	-30%	-$60.7M	0.03%	499
2023 Q3	$208M	Sell	1,535,990 -246,489	-14%	-$33.7M	0.04%	366
2023 Q2	$255M	Sell	1,782,479 -107,456	-6%	-$15.8M	0.05%	336
2023 Q1	$262M	Buy	1,889,935 +14,638	+0.8%	+$1.97M	0.06%	308
2022 Q4	$254M	Sell	1,875,297 -64,070	-3%	-$8.03M	0.06%	306
2022 Q3	$213M	Sell	1,939,367 -2,196,088	-53%	-$279M	0.06%	315
2022 Q2	$546M	Sell	4,135,455 -415,924	-9%	-$54.6M	0.14%	147
2022 Q1	$604M	Sell	4,551,379 -102,960	-2%	-$12.3M	0.13%	148
2021 Q4	$542M	Sell	4,654,339 -35,000	-0.7%	-$4.12M	0.11%	176
2021 Q3	$563M	Buy	4,689,339 +4,674,648	+31,820%	+$544M	0.12%	158
2021 Q2	$1.76M	Hold	14,691	–	–	﹤0.01%	2038
2021 Q1	$1.46M	Hold	14,691	–	–	﹤0.01%	2017
2020 Q4	$1.47M	Hold	14,691	–	–	﹤0.01%	1986
2020 Q3	$1.61M	Sell	14,691 -117,172	-89%	-$13M	﹤0.01%	1983
2020 Q2	$13.9M	Sell	131,863 -9,714	-7%	-$1M	﹤0.01%	1618
2020 Q1	$12.6M	Buy	141,577 +105,121	+288%	+$9.9M	﹤0.01%	1498
2019 Q4	$3.63M	Buy	+36,456	New	+$3.43M	﹤0.01%	1938
2019 Q1	–	Sell	-136,084	Closed	-$10.3M	–	2118
2018 Q4	$10.3M	Sell	136,084 -65,479	-32%	-$5.11M	﹤0.01%	1730
2018 Q3	$16M	Buy	201,563 +51,177	+34%	+$3.87M	0.01%	1640
2018 Q2	$10.6M	Hold	150,386	–	–	﹤0.01%	1790
2018 Q1	$10.5M	Hold	150,386	–	–	﹤0.01%	1727
2017 Q4	$10.4M	Hold	150,386	–	–	﹤0.01%	1721
2017 Q3	$10.2M	Hold	150,386	–	–	﹤0.01%	1730
2017 Q2	$10.3M	Hold	150,386	–	–	﹤0.01%	1731
2017 Q1	$9.37M	Hold	150,386	–	–	﹤0.01%	1755
2016 Q4	$8.22M	Hold	150,386	–	–	﹤0.01%	1760
2016 Q3	$9.44M	Hold	150,386	–	–	﹤0.01%	1682
2016 Q2	$9.08M	Hold	150,386	–	–	﹤0.01%	1666
2016 Q1	$8.47M	Hold	150,386	–	–	﹤0.01%	1649
2015 Q4	$10.2M	Hold	150,386	–	–	0.01%	1579
2015 Q3	$9.57M	Sell	150,386 -546,943	-78%	-$36M	0.01%	1584
2015 Q2	$44.4M	Hold	697,329	–	–	0.02%	705
2015 Q1	$47.7M	Hold	697,329	–	–	0.02%	671
2014 Q4	$49.1M	Hold	697,329	–	–	0.02%	650
2014 Q3	$49.8M	Sell	697,329 -697,329	-50%	-$51M	0.03%	622
2014 Q2	$104M	Buy	1,394,658 +697,329	+100%	+$50.4M	0.03%	607
2014 Q1	$45.2M	Hold	697,329	–	–	0.03%	630
2013 Q4	$41.4M	Hold	697,329	–	–	0.02%	656
2013 Q3	$36.2M	Hold	697,329	–	–	0.02%	736
2013 Q2	$33M	Buy	+697,329	New	+$35.5M	0.02%	726

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Norges Bank's AZN Position: Q1 2026 in Review

Norges Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 638,091 shares — an estimated $117M sold.

Norges Bank first reported a position in AZN in Q2 2013 and held it in 47 quarters. The position peaked at $604M in Q1 2022. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Norges Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 638,091 AstraZeneca shares in Q1 2026, an estimated $117M.
Norges Bank first reported a position in AstraZeneca in Q2 2013 and held it in 47 quarters.
Norges Bank's AstraZeneca position peaked at $604M in Q1 2022.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.